Preparation of Artificial Antigen and Immunological Trait for Aflatoxin B1  by Zhang, H.T. & Wang, Z.L.
Procedia Engineering 29 (2012) 4007 – 4011
1877-7058 © 2011 Published by Elsevier Ltd.
doi:10.1016/j.proeng.2012.01.610
Available online at www.sciencedirect.com
Available online at www.sciencedirect.com
 
           Procedia Engineering  00 (2011) 000–000 
Procedia
Engineering
www.elsevier.com/locate/procedia
2012 International Workshop on Information and Electronics Engineering (IWIEE) 
Preparation of Artificial Antigen and Immunological Trait for 
Aflatoxin B1 
H. T. Zhanga, Z. L. Wanga,b* 
aCollege of Animal Science, Henan Institute of Science and Technology, Xinxiang, 453003, China 
bHenan Provincial  Laboratory for Key Disciplines of Animal Virosis Control and Residues Supervison, Xinxiang  453003, China 
 
 
Abstract 
This paper reports an indirect competitive enzyme-linked immunosorbent assay (icELISA) using polyclonal antibody 
for rapid, sensitive analysis of Aflatoxin B1 (AFB1) residue. After derivation with semi-methyl hydroxylamine 
hydrochloride, AFB1 was coupled to bovine serum albumin (BSA) and ovalbumin (OVA) through N-
hydroxysuccinimide (NHS) method, and the conjugation ratio of AFB1-BSA was 18.2:1. Using mouse anti-
AFB1 polyclonal antibody, two icELISA standard curves were established. The optimal concentrations of the 
coated AFB1-OVA and anti-AFB1 pAb were 2 μg/mL, and 0.05 μg/mL in 1:16 000 dilutions, respectively. The 
blocking buffer contained BSA (1%, w/v) in PBS and assay solution of pyridine/methanol/PBS (10:20:70, v/v/v) 
were also selected. Based on the checkerboard titration, IC50 values of two standard curves were determined to be 
2.68 and 3.74 ng/mL. Therefore, the established icELISA provides a useful screening method for quantitative, or 
qualitative detection of AFB1 residue in feeds. 
 
© 2011 Published by Elsevier Ltd. 
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1. Introduction 
Aflatoxins are mainly produced by Aspergillus flavus and A. parasiticus and are found in various 
agricultural commodities. Aflatoxins are hepatotoxic and carcinogenic, and numerous epidemiological 
studies have linked consumption of aflatoxin-contaminated food with liver cancer, hepatic failure 
resulting in death and impaired child growth [1-2]. Among the aflatoxins identified, aflatoxin B1 (AFB1) 
is the predominant form, presents the highest toxic potential, and is classified as carcinogenic to humans 
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by the International Agency for Research on Cancer [3]. AFB1 mainly decreases lymphoid cell 
populations especially circulating activated lymphocytes, suppresses lymphoblastogenesis and impairs 
both cutaneous delayed-type hypersensitivity (DTH) and graft versus host reaction [4]. 
European Union legislation has established maximum permissible levels of 2-8 mg/Kg for AFB1 and 
4-15 mg/Kg for total aflatoxins, depending on the different foods (peanuts, fruits, dried fruit and its 
derived products, and cereal and its derived products) used for direct human consumption or as 
ingredients in other food products [5]. Conventional analytical methods for mycotoxins include thin-layer 
chromatography (TLC) [6], high-performance liquid chromatography (HPLC) [7], and gas 
chromatography (GC) [8]. Competition within the food and feed industry is forcing manufacturers to 
reduce costs, so that rapid, less expensive, and easier-to-use enzyme-linked immunoabsorbent assay 
(ELISA) methods for mycotoxin analysis have become increasingly important. 
In the present study, our prime objective was to synthesize the artificial antigen of AFB1, and identify 
immunological trait of mouse anti-AFB1 polyclonal antibody. The synthesized artificial antigen for AFB1 
and produced polyclonal antibodies potentially optimize the pre-treatment procedures for LC-MS and GC-
MS detection, lay a solid foundation for AFB1 ELISA kit and test strip development. 
2. Materials and Methods 
2.1. Materials and equipments 
Aflatoxin B1 (AFB1) was purchased from Dr Company, Germany. N, N’-dicyclohexylcarbodiimide 
(DCC), freund's complete adjuvant (FCA) and freund's incomplete adjuvant (FIA) were obtained from 
Pierce while N-hydroxysuccinimide (NHS) was from Japan, MSDS available. Succinic anhydride, 
bovine serum albumin (BSA) and Ovoalbumin (OVA) were supplied by Sigma while Dialysis bag was 
from Solarbio Company. GaMIgG-HRP was purchased from Sino-American Biotechnology Company 
(Shanghai, China). Semi-methyl hydroxylamine hydrochloride (SMH), tetramethylbenzidine (TMB), 
phenacetin, urea peroxide were obtained from Sigma Company. All other solvents and reagents were of 
analytical grade or higher, unless otherwise stated. 
UV-visible spectra were obtained by using a DU800 Ultraviolet-visible Spectrophotometer (Beckman-
Coulter Company, USA). A spectrophotometric microtitre reader, MULTISKAN MK3 (Thermo company, 
USA), provided with a 450 nm filter, was used for absorbance measurements.  
2.2. Synthesis and identification of AFB1 artificial antigen 
AFB1-SMH oxime hapten was introduced, based on the described methods [9]. To a solution of 2 mg 
AFB1 in 3 mL solution (0.5 mL anhydrous pyridine + 2 mL methanol + 0.5 mL distilled water ), 4 mg 
SMH was added, and then the mixture was stirred in the absence of light, kept at 50  for ℃ 12 h. 
After pyridine removed with nitrogen evaporator, the remainders were dissolved with 10 mL 
ethyl acetate and washed with water three times. After the organic solution desiccated by 
anhydrous sodium sulfate, methanol was removed by a rotary evaporator under reduced pressure 
and the synthesized product was AFB1-SMH oxime hapten. 
 Optimized NHS method was employed to synthesize the artificial antigen of AFB1. Briefly, 1 mg 
AFB1-SMH oxime hapten was suspended in 2 mL anhydrous tetrahydrofuran and then 0.598 mg NHS 
and 1.073 DCC were added. During the following 24h incubation in dark champer, the mixture was 
stirred with a HY-4 Reciprocal Shaker at 37 ℃. After centrifuged (4000 r/min, 5 min), the supernatant 
was added dropwise to 8.6 mg of BSA dissolved in 5 mL 0.13 mol/L NaHCO3, pH 7.6, kept at room 
temperature. The resulting mixture was stirred by rotor in dark champer at 37 ℃ for 1 h, and then 
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incubated with a Reciprocal Shaker for 3 h. After centrifuged (3000 r/min, 10 min), the obtained 
supernatant was dialyzed against distilled water (3 times, 8 h/time) and followed by PBS for 4 days (8 
h/time). When the micromolecule absorption peak of the dialyzed solution was disappeared, checked by 
UV-visible spectra, stored the artificial immunogen in ampoule, kept at –20 ℃. The synthetic pathway for 
AFB1-BSA complete antigen is shown in Fig. 1. An AFB1-OVA coating antigen was prepared in a 
similar way. UV-visible spectra were recorded on a DU800 Ultraviolet-visible spectrophotometer, and the 
extents of coupling were determined according to the method described by Watanabe et al. [10]. 
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Fig. 1. Synthesis procedure for AFB1 artificial antigen through NHS method 
2.3. Production of mouse anti-AFB1 polyclonal antibody 
Polyclonal antibodies against AFB1-BSA derivative were produced in inbred female Balb/c mice. 
Briefly, 60 μg artificial antigen was subcutaneously injected at four sites in the animals’ backs, as an 
emulsion of 200 μL in PBS and Freund’s complete adjuvant (FCA). Three weeks after the initial 
immunization, four booster injections were given at intervals of 2 weeks with the same conjugate in PBS 
and Freund’s incomplete adjuvant (FIA). Seven days after the last immunization, mice were tail-bled and 
the serum antibody was centrifuged at 3000 r/min for 5 min, then for subsequent determination. 
Titer of the antibody was tested by indirect ELISA. Coating antigen of AFB1-OVA was appropriately 
diluted in CBS and 100 μL were added to each well of the plates. After 2 h incubation at 37 ℃, the plates 
were washed with PBST three times and blocked with 250 μL/well of blocking buffer, followed by 
incubation for 1 h at 37 ℃. After washing, the antisera (50 μL/well) serially diluted with PBS (from 
1:100 dilution) was then added. The plate was incubated for 15 min at 37 ℃ and followed by washing. 
Then GaMIgG-HRP (1:1000, 50 μL/well) was added, followed by incubation for 25 min at 37 ℃ in a 
DH-360A oven. Plates were washed again as above and 60 μL/well of TMB substrate solution was added, 
followed by incubation for 15 min at room temperature. The enzymatic reaction was stopped with sulfuric 
acid (2 M, 100 μL/well) and the yellow plate was spectrophotometrically read at 450 nm. 
Competitive inhibition curves against AFB1 were performed based on the previous concentrations. 
The combination showing the lowest IC50 value was selected as the optimal condition for further 
development, resulting in the following protocol. To each well of a 96-well plate, 100 μL of coating 
antigen was added and incubated for 1 h at 37 ℃. The plate was washed three times and blocked with 250 
μL/well of blocking buffer, followed by incubation for 2 h at 37 ℃. After another washing procedure, 
varying concentration of AFB1 (50 μL/well) was added, followed by equal volume of antiserum diluted 
in PBS, and the following steps were similar to the indirect ELISA procedures described above. 
The calibration curves were fitted based on the average of 3 separate assays in triplicate and sensitivity 
was evaluated according to the inhibition rate. IC50 values were calculated to determine the sensitivity, 
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which represented the concentration of AFB1 that produced 50% inhibition of antiserum binding to the 
hapten conjugate. The detection of limit (LOD) was defined as the lowest concentration of AFB1 that 
exhibits a signal of 15% inhibition [11]. The dynamic range for the icELISA was calculated as the 
concentration of the analyte providing a 20–80% inhibition rate (IC20–IC80 values) of the maximum signal. 
3. Results and Analysis 
3.1. UV-vis spectrogram and Molar rate of conjugates 
UV-vis spectrum for AFB1-BSA, AFB1, and BSA are calculated (data not shown). The absorbance for 
AFB1-BSA (275 and 361 nm) gave a significant shifted peak at 275 nm compared with the 265 nm peak 
for AFB1 (265 and 365 nm), while the maximum absorbance of BSA was at 278 nm, which indicated that 
AFB1 was successfully conjugated with BSA. The coating antigen of AFB1-OVA gave a UV pattern 
similar to that of immunogen. Calculated from the formula [10], the molar ratio of 18.2:1 for AFB1-BSA 
conjugate was obtained, and the conjugation ratio for AFB1-OVA was 6.8:1. 
3.2. Optimum concentrations by checkerboard titration 
To determine the optimum concentrations of antibody and AFB1-OVA providing the highest 
sensitivity, the absorbance values were investigated. The optimal reagent concentrations are determined 
as those that give the maximum absorbance (Amax) value ranging from 1.5 to 2.0 and have the lowest IC50, 
using a checkerboard titration. A competitive binding reaction is carried out between AFB1 and the 
AFB1-OVA immobilized on the plate, and lower concentrations of coating antigens can lead to a higher 
inhibition of the analyte in solution. Therefore, optimal concentrations of the coated AFB1-OVA and 
anti-AFB1 pAb were 2 μg/mL, and 0.05 μg/mL in 1:16 000 dilutions, respectively. 
3.3. Establishment of icELISA standard curves 
The blocking step is important to avoid nonspecific absorption in the ELISAs. Otherwise, unoccupied 
sites of the plates may absorb the components, which may cause high background. As a result, the 
blocking buffer contained BSA (1%, w/v) in PBS showed a better result, so it was selected. The organic 
solvents to dissolve the AFB1 were also evaluated. Increasing the concentration of pyridine generally 
decreased and then increased the IC50 value, while increasing the concentration of methanol in the assay 
solution generally caused a continuous decrease in the Amax value but a continuous increase in the time 
for color development. Therefore, pyridine/methanol/PBS (10:20:70, v/v/v) was selected. 
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Fig. 2. Optimized standard icELISA inhibition curves for AFB1. Data were obtained by averaging three independent curves 
After optimization, two representative standard inhibition curves are shown in Fig. 2. The competitive 
curve obtained with the N0.1 mouse allowed the detection of AFB1 from 0.04 to 86 ng/mL, with IC50 and 
LOD values of 2.68 and 0.02 ng/mL. Using the N0.2 mouse, the analyte could be determined in the 0.05-
96 ng/mL range, with IC50 and LOD values of 3.74 and 0.002 ng/mL, respectively. 
4. Conclusion 
In this study, we have successfully synthesized the artificial antigen of AFB1. With simple and fast 
sample preparation, the established icELISA method has the potential to be incorporated into a 
quantitative monitoring program for the rapid screening of AFB1 residue. This ELISA could also be 
performed on farms or feed mills for food safety supervision on site. 
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